INMED PHARMACEUTICALS INC. Accrued Liabilities and Other Liabilities
INMED PHARMACEUTICALS INC. (INM) had Accrued Liabilities and Other Liabilities of $270.44 thousand as of 2022-06-30, per its 10-K filed 2022-09-23.
Discontinued › Notes › Payables and Accruals
us-gaap:AccruedLiabilitiesAndOtherLiabilities · last filed 2022-09-23
- 2022-06-30: Accrued Liabilities and Other Liabilities $270.44K.
- 2022-03-31: Accrued Liabilities and Other Liabilities $115.12K.
- 2021-12-31: Accrued Liabilities and Other Liabilities $382.11K.
- 2021-09-30: Accrued Liabilities and Other Liabilities $137.55K.
| Period end | Accrued Liabilities and Other Liabilities | Accrued Liabilities and Other Liabilities as first filed |
|---|---|---|
| 2022-06-30 | $270.44K 10-K · filed 2022-09-23 | |
| 2022-03-31 | $115.12K 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $382.11K 10-Q · filed 2022-02-14 | |
| 2021-09-30 | $137.55K 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $169.64K 10-K · filed 2022-09-23 | |
| 2021-03-31 | $65.57K 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $364.84K 10-Q · filed 2021-02-11 | |
| 2020-09-30 | $498.00K 10-Q · filed 2020-12-17 | |
| 2020-06-30 | $171.44K 10-K · filed 2021-09-24 | $401.00K 10-Q · filed 2020-12-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |